Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF) - Trial NCT03169803
Access comprehensive clinical trial information for NCT03169803 through Pure Global AI's free database. This phase not specified trial is sponsored by NeuroTronik Inc. and is currently status unknown. The study focuses on Heart Failure Acute. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
NeuroTronik Inc.
Timeline & Enrollment
N/A
May 19, 2017
Jun 19, 2019
Primary Outcome
Arterial blood pressure,Heart Rate
Summary
A feasibility study to investigate the safety and performance of the NeuroTronik Cardiac
 Autonomic Nerve Stimulation (CANS) Therapy System
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03169803
Device Trial